De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on Survival
Open Access
- 22 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 11 (1) , 89-97
- https://doi.org/10.1002/lt.20319
Abstract
Immunosuppression increases the risk of posttransplant malignancy and it may increase posttransplant mortality. The finding of factors related to the development of posttransplant malignancy may serve as a guide to avoid those risk factors and to develop strategies of posttransplant surveillance. The incidence and risk factors of malignancy were studied in 187 consecutive liver transplant recipients surviving more than 3 months. None of the 12 patients surviving less than 3 months had de novo neoplasia. The impact of malignancy on survival was studied in a case-control study. After a median follow-up of 65 months, 49 patients developed 63 malignancies: 25 patients had 35 cutaneous neoplasias and 27 patients had 28 noncutaneous malignancies. The 5- and 10-year actuarial rates of cutaneous neoplasia were 14 and 24% and the rates of noncutaneous neoplasia were 11 and 22%, respectively. Risk factors for the development of cutaneous malignancy were older age and Child-Turcotte-Pugh A status. Risk factors for the development of noncutaneous malignancy were older age, alcoholism, and smoking. Cutaneous neoplasia had no effect on survival, whereas patients with noncutaneous malignancy had a significant reduction of survival. The overall relative risk of cutaneous and noncutaneous neoplasia, as compared with the general population were 16.91 (95% confidence interval: 11.78-23.51) and 3.23 (95% confidence interval: 2.15-4.67), respectively. The relative risk of cancer-related mortality (after excluding recurrent malignancy) was 2.93 (95% confidence interval: 1.56-5.02). Multivariate analysis showed that noncutaneous malignancy was an independent risk factor for posttransplant mortality. In conclusion, liver transplant recipients have a higher risk of cancer-related mortality than the general population. This increased risk is due to the development of noncutaneous neoplasia. Older age, alcoholism, and smoking increase the risk of de novo noncutaneous neoplasia.Keywords
This publication has 22 references indexed in Scilit:
- De Novo Internal Neoplasms after Liver Transplantation: Increased Risk and Aggressive Behavior in Recent Years?American Journal of Transplantation, 2004
- Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of MalignancyAmerican Journal of Transplantation, 2003
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantationLiver Transplantation, 2002
- De novo tumors after liver transplantation: A single-institution experienceLiver Transplantation, 2002
- Risk factors for development of de novo neoplasia after liver transplantationLiver Transplantation, 2001
- Analysis of causes of death in liver transplant recipients who survived more than 3 yearsLiver Transplantation, 2001
- Prognostic model for early acute rejection after liver transplantationLiver Transplantation, 2001
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- INCREASED INCIDENCE OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSISTransplantation, 1999